Skip to main content
Clinical Trials/NCT02118259
NCT02118259
Completed
Not Applicable

Impact of Multidisciplinary Review of Drug Prescriptions on Patient Safety in a Residence for Dependent Elderly

Centre Hospitalier Universitaire de Nīmes2 sites in 1 country49 target enrollmentMay 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Geriatrics
Sponsor
Centre Hospitalier Universitaire de Nīmes
Enrollment
49
Locations
2
Primary Endpoint
Adverse Drug Events Geriatric Risk Score
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The main objective of the study is to show that the multidisciplinary review of drug prescriptions changes the adverse drug event (ADE) geriatric risk score (according to Trivalle and Ducimetière 2013) for patients living in the Nîmes University Hospital Residence for Dependent Elderly.

Detailed Description

The secondary objectives of this study are to assess and compare the following criteria before and after multidisciplinary review of drug prescriptions for patients in the Nîmes University Hospital Residence for Dependent Elderly: A. the number of patients with at least one potentially inappropriate drug prescribed B. the number of hospitalizations C. death rate D. the number of falls per patient and the rate of fallers E. qualitative criteria describing the drug review F. associated care costs

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
February 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Centre Hospitalier Universitaire de Nīmes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The patient (or his/her legal representative) must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for 6 months of follow-up
  • The patient has resided at the Nîmes University Hospital Residence for Dependent Elderly for at least the past 6 months

Exclusion Criteria

  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection
  • The patient (or his/her legal representative) refuses to sign the consent
  • It is impossible to correctly inform the patient (or his/her legal representative)
  • The patient has resided at the Nîmes University Hospital Residence for Dependent Elderly for less than 6 months

Outcomes

Primary Outcomes

Adverse Drug Events Geriatric Risk Score

Time Frame: change from Baseline to 6 months

according to Trivalle and Ducimetière 2013

Secondary Outcomes

  • The number of patients taking at least 1 potentially inappropriate drug according to Laroche criteria(During the proactive phase. Day 0.)
  • Number of hospitalizations in the public sector (higher level care)(second observational phase (day 0 to month 6))
  • Days of hospitalization in the public sector (higher level care)(second observational phase (day 0 to month 6))
  • Mortality(second observational phase (day 0 to month 6))
  • The number of falls per patient(second observational phase (day 0 to month 6))
  • The percentage of patients who fell(second observational phase (day 0 to month 6))
  • The Anatomical Therapeutic Chemical classification for each revised drug(during the proactive phase (day 0))
  • The type of errors detected during drug review(during the proactive phase (day 0))
  • The type of modification suggested during drug review(during the proactive phase (day 0))
  • The acceptation rate for modifications suggested during drug review(during the proactive phase (day 0))
  • Associated care costs (€)(second observational phase (day 0 to month 6))

Study Sites (2)

Loading locations...

Similar Trials